Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,849 | -32,280 | -36,415 | -13,587 | -15,133 |
| Depreciation Amortization | 1,020 | 872 | 814 | 655 | 484 |
| Accounts receivable | 6,688 | -4,898 | -2,196 | -3,632 | -961 |
| Accounts payable and accrued liabilities | 1,246 | -1,939 | -61 | 564 | 56 |
| Other Working Capital | -1,231 | -5,464 | 1,593 | 181 | 447 |
| Other Operating Activity | 12,261 | 15,562 | 23,066 | 2,182 | 1,578 |
| Operating Cash Flow | $-14,865 | $-28,146 | $-13,199 | $-13,637 | $-13,530 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3,131 | 44 | 8,963 | -12,055 | N/A |
| PPE Investments | -375 | -1,029 | -509 | -882 | -787 |
| Net Acquisitions | N/A | -7,000 | -11,556 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -7,000 | 0 | 0 |
| Investing Cash Flow | $2,756 | $-7,986 | $-10,102 | $-12,937 | $-787 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 11,768 |
| Debt Issued | N/A | 10,528 | N/A | 9,905 | N/A |
| Debt Repayment | -11 | -9,538 | -4,000 | -1,193 | N/A |
| Common Stock Issued | 21,601 | 4,952 | 12,660 | 0 | 246 |
| Other Financing Activity | -129 | 12,848 | -6,250 | 53,215 | -588 |
| Financing Cash Flow | $21,461 | $18,790 | $2,410 | $61,927 | $11,426 |
| Exchange Rate Effect | -240 | 263 | 60 | 117 | 64 |
| Beginning Cash Position | 2,674 | 19,752 | 40,583 | 5,112 | 7,938 |
| End Cash Position | 11,785 | 2,674 | 19,752 | 40,583 | 5,112 |
| Net Cash Flow | $9,112 | $-17,079 | $-20,830 | $35,470 | $-2,826 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,865 | -28,146 | -13,199 | -13,637 | -13,530 |
| Capital Expenditure | -375 | -1,029 | -509 | -882 | -787 |
| Free Cash Flow | -15,239 | -29,175 | -13,708 | -14,519 | -14,317 |